Skip to main content

Goldman Sachs: Madrigal Pharma Has Blockbuster Potential In Liver, Cholesterol Treatments

By: via Benzinga
Madrigal Pharmaceuticals Inc (NASDAQ: MDGL), a clinical-stage biotechnology company, could spring a surprise in thenon-alcoholic ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.